Page last updated: 2024-08-17

levodopa and malondialdehyde

levodopa has been researched along with malondialdehyde in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's4 (40.00)18.2507
2000's1 (10.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdallah, RM; Meadows, GG; Pierson, HF1
Meadows, GG; Pierson, HF1
Ahlskog, JE; Kokmen, E; Low, PA; Nickander, KK; Petersen, RC; Tyce, GM; Uitti, RJ1
Ahlskog, JE; Low, PA; Nickander, KK; O'Brien, JF; Tyce, GM; Uitti, RJ1
Bogomolov, OV; Borisova, NV; Iurasov, VV; Kaplun, AP; Kryzhanovskiĭ, GN; Kucherianu, VG; Nikushkin, EV; Shvets, VI; Zhigal'tsev, IV1
Bermak, J; Weingarten, P; Zhou, QY1
Farag, NE; Hammad, LN; Zaitone, SA1
Chen, C; Fan, Q; Huang, J; Pan, X; Wei, H1
Gadjeva, V; Karamalakova, Y; Kovacheva, N; Nikolova, G; Stanev, S; Zheleva, A1
Jiang, MD; Wang, JL; Wang, YF; Zheng, Y1

Other Studies

10 other study(ies) available for levodopa and malondialdehyde

ArticleYear
Ascorbate in the treatment of experimental transplanted melanoma.
    The American journal of clinical nutrition, 1991, Volume: 54, Issue:6 Suppl

    Topics: Animals; Ascorbic Acid; Dehydroascorbic Acid; Female; Levodopa; Lung Neoplasms; Male; Malondialdehyde; Melanoma, Experimental; Mice; Neoplasm Transplantation

1991
Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation.
    Journal of the National Cancer Institute, 1985, Volume: 75, Issue:3

    Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lipid Peroxides; Liver; Malondialdehyde; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Phenylalanine; Tyrosine

1985
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5

    Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Brain; Cabergoline; Carbidopa; Diabetes Mellitus; Ergolines; Female; Free Radicals; Humans; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Selegiline; Vitamin E

1995
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.
    Neurology, 1996, Volume: 46, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Cysteinyldopa; Humans; Levodopa; Malondialdehyde; Methoxyhydroxyphenylglycol; Middle Aged; Oxidative Stress; Parkinson Disease; Selegiline

1996
[Oxidation in liposomes from egg phosphatidylcholine loaded with L-3,4-dihydroxyphenylalanine (DOPA) and dopamine: mutual effect of components].
    Bioorganicheskaia khimiia, 1997, Volume: 23, Issue:4

    Topics: Dopamine; Eggs; Kinetics; Levodopa; Lipid Bilayers; Lipid Peroxidation; Liposomes; Malondialdehyde; Oxidation-Reduction; Phosphatidylcholines

1997
Evidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidants.
    Journal of neurochemistry, 2001, Volume: 76, Issue:6

    Topics: Acetylcysteine; Aldehydes; Animals; Antioxidants; Aromatic-L-Amino-Acid Decarboxylases; Aspirin; Cell Survival; CHO Cells; Clone Cells; Cricetinae; Dopamine; Glutathione; L-Lactate Dehydrogenase; Levodopa; Lipid Peroxidation; Malondialdehyde; NF-kappa B; Recombinant Proteins

2001
Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:5

    Topics: Animals; Antioxidants; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Carbidopa; Catalase; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Glutathione Peroxidase; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Mice; Motor Activity; Oxidative Stress; Parkinsonian Disorders; Superoxide Dismutase

2013
Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Neuroscience letters, 2015, Jul-23, Volume: 600

    Topics: Animals; Apomorphine; Benserazide; Combined Modality Therapy; Drug Combinations; Glial Fibrillary Acidic Protein; Glutathione Peroxidase; Hyperbaric Oxygenation; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase

2015
Protective effect of two essential oils isolated from Rosa damascena Mill. and Lavandula angustifolia Mill, and two classic antioxidants against L-dopa oxidative toxicity induced in healthy mice.
    Regulatory toxicology and pharmacology : RTP, 2016, Volume: 81

    Topics: Animals; Antioxidants; Antiparkinson Agents; Brain; DNA Damage; Lavandula; Levodopa; Male; Malondialdehyde; Mice; Oils, Volatile; Oxidative Stress; Phytotherapy; Plant Extracts; Plant Oils; Plants, Medicinal; Protein Carbonylation; Reactive Nitrogen Species; Reactive Oxygen Species; Rosa; Spectrophotometry

2016
Drug induces depression-like phenotypes and alters gene expression profiles in Drosophila.
    Brain research bulletin, 2017, Volume: 132

    Topics: Animals; Chlorpromazine; Depressive Disorder, Major; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Eating; Female; Gene Expression; Levodopa; Male; Malondialdehyde; Maternal Exposure; Paternal Exposure; Serotonin; Sexual Behavior, Animal; Superoxide Dismutase

2017